Скачать или смотреть ‘iNCOVACC’ to produce three immune responses: Bharat Biotech MD after nasal vaccine launch

Briefing about the factors of the intranasal vaccine 'iNCOVACC' launched by Bharat Biotech, company’s Executive Chairman Dr Krishna M Ella on January 26 said that the vaccine, unlike any other in the world, can produce three immune responses; IgG, IgA, and T cell. He further informed that the vaccines are easy to deliver and do not require any syringe or needle.
“It's easy to deliver and doesn't need any syringe or needle and most important it produces three immune responses, IgG, IgA, and T cell response. No other vaccine in the world can produce three responses,” the Bharat Biotech

#BharatBiotech #NasalVaccine #CovidVaccine

Subscribe now and press the bell icon 🔔 to get new video updates: https://bit.ly/2UV4ygi
--------------------------------------
ANI is South Asia's leading Multimedia News Agency providing content for every information platform, including TV, Internet, broadband, newspapers, and mobiles.
Subscribe now! Enjoy and stay connected with us!!
☛ Subscribe to ANI News YouTube channel: https://bit.ly/2UV4ygi
☛ Visit our Official website: https://www.aninews.in/
☛ Follow ANI:   / ani  
☛ Like us:   / aninews.in  
☛ Email to: [email protected], [email protected]
☛ Copyrights © All Rights Reserved ANI Media Pvt Ltd.